HIV-1 subtypes B, G and CRF02_AG transmission cluster in Migrants population followed in Portugal based on sequence data

European Meeting on HIV & Hepatitis 2021

Prevention Trials in the Last Year What Have We Learned | Sheena McCormack, MD

European HIV Clinical Forum 2021

HIV Transmission Clusters in Europe: A Perspective View of Late Presenters and Non-Late Presenters

European Meeting on HIV & Hepatitis 2022

Maraviroc as a Latency Reversing Agent in cell line models - Filippo Dragoni

European Meeting on HIV & Hepatitis 2019

Introduction Session 5 | Jeffrey Lazarus, PhD, MIH, MA

International Viral Hepatitis Elimination Meeting (IVHEM) 2018

First line therapy - Sharon Walmsley, FRCPC, MD, MSC

São Paulo HIV Clinical Forum 2020

Modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017

Current status of HIV: the importance of comorbidities. Do we have to worry about the quality of life of our HIV patients? - Maria Jose Galindo

European Workshop on Healthy Living with HIV 2019

Personalized Treatment Regimens | Josep M. Llibre

European Meeting on HIV & Hepatitis 2024

COVID-19, Me and Clinical Pharmacology - Dr. Andrea Calcagno

Liverpool Course 2020